Seaport Therapeutics, Inc.

Listed Company
SPTXCIK 0002042347NasdaqNon-AcceleratedSmaller ReportingEmerging GrowthPharmaceutical PreparationsDelawareFY ends Dec 31
SPTX$20.91+7.21% · past 3 monthsDBEQ Basic
Daily closing prices

Business

Seaport Therapeutics, Inc. is a publicly listed company in Pharmaceutical Preparations, incorporated in Delaware. Common stock trades on Nasdaq under the ticker SPTX.

Auto-generated from company profile

Financials

Financial data not availableNo XBRL filings found for this entity.

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Seaport Therapeutics, Inc.'s CIK number?

Seaport Therapeutics, Inc.'s SEC CIK number is 0002042347 (2042347). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Seaport Therapeutics, Inc.'s SEC filings?

All of Seaport Therapeutics, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did Seaport Therapeutics, Inc. last report earnings?

Seaport Therapeutics, Inc. (SPTX) most recently filed an earnings 8-K with the SEC on Jun 8, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001193125-26-260671). This is Seaport Therapeutics, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.

What is Seaport Therapeutics, Inc.'s most recent earnings 8-K?

Seaport Therapeutics, Inc.'s latest earnings 8-K (Item 2.02) was filed Jun 8, 2026 under accession 0001193125-26-260671. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View Seaport Therapeutics, Inc.'s latest earnings 8-K →
Look up any company's CIK number →